292 related articles for article (PubMed ID: 34986284)
21. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy.
Yamazaki H; Ohta K; Iida H; Imada K; Obara N; Tokumine Y; Tomiyama Y; Usuki K; Imajo K; Miyamura K; Sasaki O; Fanghong Z; Hattori T; Tajima T; Matsuda A; Nakao S
Int J Hematol; 2019 Aug; 110(2):187-196. PubMed ID: 31183813
[TBL] [Abstract][Full Text] [Related]
22. Eltrombopag for the treatment of aplastic anemia: current perspectives.
Lum SH; Grainger JD
Drug Des Devel Ther; 2016; 10():2833-2843. PubMed ID: 27695288
[TBL] [Abstract][Full Text] [Related]
23. Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia.
Gao Q; Zhang L; Zhao X; Zhu Y; Peng G; Li Y; Li Y; Li J; Song L; Ye L; Fan H; Zhou K; Yang W; Yang Y; Jing L; Zhang F
Hematology; 2020 Dec; 25(1):341-347. PubMed ID: 32915111
[No Abstract] [Full Text] [Related]
24. Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
Olnes MJ; Scheinberg P; Calvo KR; Desmond R; Tang Y; Dumitriu B; Parikh AR; Soto S; Biancotto A; Feng X; Lozier J; Wu CO; Young NS; Dunbar CE
N Engl J Med; 2012 Jul; 367(1):11-9. PubMed ID: 22762314
[TBL] [Abstract][Full Text] [Related]
25. Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag.
Li R; Zhou J; Liu Z; Chen X; Long Q; Yang Y; Lin S; Jia J; He G; Li J
Front Immunol; 2022; 13():884312. PubMed ID: 35720405
[TBL] [Abstract][Full Text] [Related]
26. A systematic review and meta-analysis of the safety and efficacy of anti-thymocyte globulin combined with eltrombopag in the treatment of severe aplastic anemia.
Zhang J; Wu Y; Liu J; Han S; Chen L; Wang H; Peng Y
Ann Palliat Med; 2021 May; 10(5):5549-5560. PubMed ID: 34107711
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
28. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Biancotto A; Wu CO; Young NS
N Engl J Med; 2011 Aug; 365(5):430-8. PubMed ID: 21812672
[TBL] [Abstract][Full Text] [Related]
29. Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag.
Zaimoku Y; Patel BA; Shalhoub R; Groarke EM; Feng X; Wu CO; Young NS
Haematologica; 2022 Jan; 107(1):126-133. PubMed ID: 33910334
[TBL] [Abstract][Full Text] [Related]
30. Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia.
de Latour RP; Kulasekararaj A; Iacobelli S; Griffin M; Halkes CJ; Dufour C; Risitano AM
Immunotherapy; 2024 Feb; 16(3):135-142. PubMed ID: 38088156
[TBL] [Abstract][Full Text] [Related]
31. Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.
Cheng H; Wang X; Zhou D; Cao J; Larochelle A; Xu KL
Ann Hematol; 2019 Aug; 98(8):2009-2011. PubMed ID: 30891613
[No Abstract] [Full Text] [Related]
32. Recent developments in drug therapy for aplastic anemia.
Willis L; Rexwinkle A; Bryan J; Kadia TM
Ann Pharmacother; 2014 Nov; 48(11):1469-78. PubMed ID: 25184310
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.
Patel BA; Groarke EM; Lotter J; Shalhoub R; Gutierrez-Rodrigues F; Rios O; Quinones Raffo D; Wu CO; Young NS
Blood; 2022 Jan; 139(1):34-43. PubMed ID: 34525188
[TBL] [Abstract][Full Text] [Related]
34. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
Marsh JC; Bacigalupo A; Schrezenmeier H; Tichelli A; Risitano AM; Passweg JR; Killick SB; Warren AJ; Foukaneli T; Aljurf M; Al-Zahrani HA; Höchsmann B; Schafhausen P; Roth A; Franzke A; Brummendorf TH; Dufour C; Oneto R; Sedgwick P; Barrois A; Kordasti S; Elebute MO; Mufti GJ; Socie G;
Blood; 2012 Jun; 119(23):5391-6. PubMed ID: 22544699
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.
McQuilten Z; Heritier S; Fox L; Fox V; Young L; Blombery P; Cunningham I; Curnow J; Higgins A; Hiwase DK; Filshie R; Firkin F; Lacaze P; Mason K; Mills AK; Pepperell D; Patil S; Stevenson W; Szer J; Waters N; Wilson K; Ting S; Wood E
BMJ Open; 2024 Jan; 14(1):e076246. PubMed ID: 38238183
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of eltrombopag in aplastic anemia: A multi-center survey in China].
Yang WR; Han B; Chang H; Wu BY; Meng FK; Ji DX; Li YM; Zheng ZJ; Fei Y; Shen JP; Hu P; Ding XQ; Zhang P; Wang YQ; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):890-895. PubMed ID: 33333690
[No Abstract] [Full Text] [Related]
37. Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of Michigan.
Foucar CE; Foley DH; Aldous J; Burke PW; Pettit KR; Benitez LL; Perissinotti AJ; Marini BL; Boonstra P; Bixby DL
Eur J Haematol; 2024 Mar; 112(3):424-432. PubMed ID: 37929654
[TBL] [Abstract][Full Text] [Related]
38. [The efficacy of eltrombopag plus cyclosporine A in patients with transfusion-dependent non-severe aplastic anemia: a retrospective study from single center].
Chen Y; Zha Q; Huang F; Qiao C; Wang Y; Wang R; Li JY; Shen WY
Zhonghua Nei Ke Za Zhi; 2022 Apr; 61(4):409-411. PubMed ID: 35340188
[TBL] [Abstract][Full Text] [Related]
39. The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
Ames NJ; Barb JJ; Ranucci A; Kim H; Mudra SE; Cashion AK; Townsley DM; Childs R; Paster BJ; Faller LL; Wallen GR
Ann Hematol; 2019 Jun; 98(6):1351-1365. PubMed ID: 30919073
[TBL] [Abstract][Full Text] [Related]
40. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
